# Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes

> **NCT02049814** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 494 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Metformin
- **DRUG:** Voglibose
- **DRUG:** Acarbose

## Key facts

- **NCT ID:** NCT02049814
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-09
- **Primary completion:** 2016-06-01
- **Final completion:** 2016-06-28
- **Target enrollment:** 494 (ACTUAL)
- **Last updated:** 2019-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02049814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02049814, "Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02049814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*